Evaluation of Intracellular Signaling Downstream Chimeric Antigen ReceptorsHannah Karlsson, Angelica Loskog|PLoS ONE|2015Cited by 108
Activation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironmentEmma Eriksson, Angelica Loskog|Gene Therapy|2016Cited by 85
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 studyBenjamin Musher, Angelica Loskog, Mohamed O. Othman et al.|The Lancet Oncology|2024Cited by 64
Preclinical Evaluation of AdVince, an Oncolytic Adenovirus Adapted for Treatment of Liver Metastases from Neuroendocrine CancerDi Yu, Magnus Essand, Justyna Leja-Jarblad et al.|Neuroendocrinology|2016Cited by 35